T1DM is an autoimmune disorder characterized by the destruction of beta cells, resulting in an absolute deficiency of insulin ...

Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une société internationale spécialisée en ophtalmologie, annonce aujourd’hui que l’administration quotidienne en une seule dos ...

2025 outlook: Organic sales growth range narrowed to 6-8% (previously 5-8%), and 7-9% excluding the exit from certain countries (previously 6-9%). Adjusted EBITDA margin is maintained at 37-38%, ...

Following a successful execution in the first half of the year, and GN’s company-wide agility, the financial guidance for 2025 is confirmed. The organic revenue growth guidance of -3% to +3% ...

Cantor is acting as sole book-running manager for the offering.

An investor webcast and conference call will be held at 9.30am AEST on Thursday 21 August 2025 (7.30pm EDT Wednesday 20 August 2025). Participants can register for the webcast by clicking here: or ...

Iantrek, Inc., a pioneer in bio-interventional ophthalmic surgery (BIOS), today announced the close of a $42 million Series C ...

Espoo, Finland, 21 August 2025: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, releases today the Company’s 1H 2025 ...

CHARLOTTE, N.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Hemp Hop, a trusted name in premium hemp products since 2018, has just ...

Le 100 % Santé n’est pas simplement une mesure technique : c’est une réforme ambitieuse qui transforme en profondeur l’accès ...

Un sourire. Parfois, il est la première chose que l’on remarque, une signature silencieuse. Pendant longtemps, l’idée d’y ...

MyndMed™’s formula, developed by BioAdaptives’ research team, incorporates a precise blend of botanical extracts, amino acids, and neuro-support nutrients designed to support neurotransmitter balance, ...